Skip to content
Search

Latest Stories

Support urged for unsuccessful Pharmacy candidates as GPhC declares results

Support urged for unsuccessful Pharmacy candidates as GPhC declares results
The GPhC and PDA are emphasize the need for robust support systems for candidates who sat the June 2024 registration assessment for pharmacists, offering guidance on mental health resources and the appeals process for those who were unsuccessful

In light of the recently announced results of the June 2024 registration assessment for pharmacists, Duncan Rudkin, Chief Executive of the General Pharmaceutical Council (GPhC) acknowledged the importance of a robust support network for candidates who did not clear the assessment.

The results announced on Tuesday (30) and jointly published by (GPhC) and the Pharmaceutical Society of Northern Ireland (PSNI) revealed that 695 out of 2,776 candidates were unsuccessful while 75 per cent successfully passed the assessment, highlighting the challenges faced by a significant portion of aspiring pharmacists.


In a statement Rudkin emphasised that failing the assessment does not mark the end of the journey, stating:

"The registration assessment is one of the ways we test trainee pharmacists to ensure they understand how to apply knowledge appropriately and in a timely way. This means they can make professional judgements when practising.

“For those who unfortunately didn’t pass the assessment, there are a range of options available, with all the relevant information on the June 2024 registration assessment page."

Furthermore, he pointed to various resources available to help candidates navigate this difficult period.

"The charity Pharmacist Support can also provide help with mental health and wellbeing as well as practical advice," Rudkin added.

Pharmacist Support provides vital assistance, including mental health and wellbeing services, which are crucial for candidates grappling with the emotional impact of not passing the assessment.

Additionally, the charity offers practical advice on next steps, including career guidance and strategies for preparing to retake the assessment.

For many candidates, particularly those who were sitting the exam for a second or third time, the pressure can be overwhelming.

The pass rates for these groups were notably lower, with only 53 per cent of second-time sitters and 59 per cent of third-time sitters passing.

This underscores the need for targeted interventions to help these candidates overcome the hurdles they face.

As the pharmacy profession continues to evolve, the GPhC and other stakeholders are being urged to ensure that all trainees, especially those who struggle, have access to the support they need.

This includes not only academic and professional guidance but also emotional and mental health resources.

Rudkin also congratulated successful candidates to passed the assessment in June.

A total of 2,776 candidates sat for the assessment, with 2,081 successfully passing, yielding an overall pass rate of 75 per cent.

"Many congratulations to the candidates who passed this year’s registration assessment. It is the culmination of years of hard work and part of the journey to becoming a registered pharmacist," he said.

Decline in success rates

The June 2024 assessment results show a slight decline in the pass rate compared to previous years, with 2023 recording a pass rate of 77 per cent, and 2022 a higher 80 per cent .

Of the 2,678 candidates who sat under the GPhC jurisdiction, 2,358 were first-time sitters, with 77 per cent of them passing.

Second-time sitters had a pass rate of 53 per cent, while third-time sitters had a pass rate of 59 per cent.

In addition to emotional and practical support, the Pharmacists' Defence Association (PDA) has reminded candidates of their right to appeal if they believe there were procedural errors or exceptional circumstances that affected their performance.

The PDA advises candidates to thoroughly review the GPhC’s guidance on appeals and gather all necessary evidence before proceeding.

"The PDA would like to remind all candidates who sat the June 2024 assessment, and feel that they have grounds to appeal on receipt of their results, to review the GPhC guidance and gather all evidence before taking action," the PDA stated.

The appeal process is strict, with valid grounds limited to procedural errors or exceptional circumstances unknown to the candidate at the time of the exam.

Appeals must be submitted by 5 pm on Tuesday, 20 August 2024, with supporting evidence provided in a clear format.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less